Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2751

Sep 19, 2010

New Plant Paradigms (Part X: Power Plants, Greening the Desert, Phyto-Terraforming, and Recommendations)

Posted by in categories: biological, biotech/medical, futurism, habitats

(End of series. For previous topics please see parts I-IX)

Power plants. Trees could do a lot, as we have seen — and they’re solar powered, too. Once trees can suck metals from the soil and grow useful, shaped objects like copper wire, a few more levels of genetic engineering could enable the tree to use this copper wire to deliver electricity. Since a tree is already, now, a solar energy converter, we can build on that by having the tree grow tissues that convert energy into electricity. Electric eels can already do that, producing enough of a jolt to be lethal to humans. Even ordinary fish produce small amounts of electricity to create electric fields in the water around them. Any object nearby disrupts the field, enabling the fish to tell that something is near, even in total darkness. We may never be able to plug something into a swimming fish but we can already make batteries out of potatoes. So why not trees that grow into electricity providers all by themselves? It would be great to be able to plug your electrical devices into a tree (or at least a socket in your house that is connected to the tree). Then you would no longer need to connect to the grid, purchase solar panels, or install a windmill. You would, however, need to keep your trees healthy and vigorous! Tree care specialists would become a highly employable occupation.

Greening the desert. The Sahara and various other less notorious but still very dry deserts around the world have plenty of sand and rocks. But they don’t have much greenery. The main problem is lack of water. Vast swaths of the Sahara, for example, are plant free. It’s just too dry. However this problem is solvable! Cacti and other desert plants could potentially extract water from the air. Plants already extract carbon dioxide molecules from the air. Even very dry air contains considerable water vapor, so why not extract water molecules too. Indeed, plants already transport water molecules in the ground into their roots, so is it really such a big step to do the same from the air? Tillandsia (air plant) species can already pull in water with their leaves, but it has to be rain or other liquid water. Creating plants that can extract gaseous water vapor from the air in a harsh desert environment would require sophisticated genetic engineering, or a leap for mother nature, but it is still only the first step. Plants get nutrients out of the soil by absorbing fluid that has dissolved them, so dry soil would be a problem even for a plant that contained plenty of water pulled from the air. Another level of genetic engineering or natural evolution would be required to enable them to secrete fluid out of their roots to moisten chunks of soil to dissolve its minerals, and reabsorb the now nutritious, mineral-laden liquid back into their roots.

Once this difficult task is accomplished, whether by natural evolution in the distant future or genetic engineering sooner, things will be different in the desert. Canopies of vegetation that hide the ground will be possible. Thus shaded and sheltered, the ground will be able to support a much richer ecosystem of creatures and maybe even humans than is currently the case in deserts. One of Earth’s harshest environments would be tamed.

Continue reading “New Plant Paradigms (Part X: Power Plants, Greening the Desert, Phyto-Terraforming, and Recommendations)” »

Jul 6, 2010

What’s your idea to BodyShock the Future?

Posted by in categories: biotech/medical, futurism

I’m working on this project with Institute for the Future — calling on voices everywhere for ideas to improve the future of global health. It would be great to get some visionary Lifeboat ideas entered!

INSTITUTE FOR THE FUTURE ANNOUNCES BODYSHOCK:
CALL FOR ENTRIES ON IDEAS TO TRANSFORM LIFESTYLES AND THE HUMAN BODY TO IMPROVE HEALTH IN THE NEXT DECADE

“What can YOU envision to improve and reinvent health and well-being for the future?” Anyone can enter, anyone can vote, anyone can change the future of global health.

Continue reading “What's your idea to BodyShock the Future?” »

Jun 7, 2010

Gizmodo: Are Cameras the New Guns?

Posted by in categories: biotech/medical, media & arts, policy

Wendy McElroy brings an important issue to our attention — the increasing criminalization of filming / recording on-duty police officers.

The techno-progressive angle on this would have to take sousveillance into consideration. If our only response to a surveillance state is to observe “from the bottom” (as, for example, Steve Mann would have it), and if that response is made illegal, it seems that the next set of possible steps forward could include more entrenched recording of all personal interaction.

Already we have a cyborg model for this — “eyeborgs” Rob Spence and Neil Harbisson. So where next?

Resources:

Continue reading “Gizmodo: Are Cameras the New Guns?” »

Apr 18, 2010

Ray Kurzweil to keynote “H+ Summit @ Harvard — The Rise Of The Citizen Scientist”

Posted by in categories: biological, biotech/medical, business, complex systems, education, events, existential risks, futurism, geopolitics, human trajectories, information science, media & arts, neuroscience, robotics/AI

With our growing resources, the Lifeboat Foundation has teamed with the Singularity Hub as Media Sponsors for the 2010 Humanity+ Summit. If you have suggestions on future events that we should sponsor, please contact partnerships@lifeboat.com.

The summer 2010 “Humanity+ @ Harvard — The Rise Of The Citizen Scientist” conference is being held, after the inaugural conference in Los Angeles in December 2009, on the East Coast, at Harvard University’s prestigious Science Hall on June 12–13. Futurist, inventor, and author of the NYT bestselling book “The Singularity Is Near”, Ray Kurzweil is going to be keynote speaker of the conference.

Also speaking at the H+ Summit @ Harvard is Aubrey de Grey, a biomedical gerontologist based in Cambridge, UK, and is the Chief Science Officer of SENS Foundation, a California-based charity dedicated to combating the aging process. His talk, “Hype and anti-hype in academic biogerontology research: a call to action”, will analyze the interplay of over-pessimistic and over-optimistic positions with regards of research and development of cures, and propose solutions to alleviate the negative effects of both.

Continue reading “Ray Kurzweil to keynote "H+ Summit @ Harvard — The Rise Of The Citizen Scientist"” »

Sep 1, 2009

Keeping genes out of terrorists’ hands

Posted by in categories: biological, biotech/medical, chemistry, counterterrorism, existential risks, policy

Nature News reports of a growing concern over different standards for DNA screening and biosecurity:

“A standards war is brewing in the gene-synthesis industry. At stake is the way that the industry screens orders for hazardous toxins and genes, such as pieces of deadly viruses and bacteria. Two competing groups of companies are now proposing different sets of screening standards, and the results could be crucial for global biosecurity.

“If you have a company that persists with a lower standard, you can drag the industry down to a lower level,” says lawyer Stephen Maurer of the University of California, Berkeley, who is studying how the industry is developing responsible practices. “Now we have a standards war that is a race to the bottom.”

Continue reading “Keeping genes out of terrorists' hands” »

Jul 26, 2009

Bioethics and the End of Discussion

Posted by in categories: biotech/medical, ethics

Abstract:

President Obama disbanded the President’s Council on Bioethics after it questioned his policy on embryonic stem cell research. White House press officer Reid Cherlin said that this was because the Council favored discussion over developing a shared consensus. This column lists a number of problems with Obama’s decision, and with his position on the most controversial bioethical issue of our time.

Bioethics and the End of Discussion

In early June, President Obama disbanded the President’s Council on Bioethics. According to White House press officer Reid Cherlin, this was because the Council was designed by the Bush administration to be “a philosophically leaning advisory group” that favored discussion over developing a shared consensus. http://www.nytimes.com/2009/06/18/us/politics/18ethics.html?_r=2

Continue reading “Bioethics and the End of Discussion” »

Jul 6, 2009

Unique opportunity to sponsor research investigating an infectious cause and potential treatment for Alzheimer’s disease

Posted by in categories: biological, biotech/medical, neuroscience

Unique opportunity to sponsor research investigating an infectious cause and potential treatment for Alzheimer’s disease



Alzheimer’s disease afflicts some 20 million people world-wide, over 5 million people of whom reside in the United States. It is currently the seventh-leading cause of death in the US. The number of people with the disease is predicted to increase by over 50% by 2030. The economic as well as emotional costs are huge, the costs being estimated as more than $148 billion each year (direct and indirect, for of all types of dementia, to Medicare, Medicaid and businesses).

The causes of Alzheimer’s disease are unknown, apart from the very small proportion with familial disease. We are investigating the involvement of infectious agents in the disease, with particular emphasis on the virus that causes oral herpes/cold sores/fever blisters. We discovered that most elderly humans harbour this virus in their brains and that in those (and only those) who possess a certain genetic factor, the virus confers a strong risk of developing Alzheimer’s disease. Also, we found that the virus is directly involved with the characteristic abnormalities seen in the brains of Alzheimer’s disease patients.

There are several treatment possibilities available to combat this virus and all would be suitable candidates as therapies in Alzheimer’s disease. However, much more research is needed before trials of these agents for Alzheimer’s disease in humans can begin.

In these financially difficult times many funding bodies have to prioritise projects based around long established hypotheses. Projects involving new avenues of investigation can receive very positive comments by scientific reviewers, yet are rarely funded, as they almost always appear risky compared with projects largely confirming or expanding existing ideas. Such conservative projects are almost guaranteed to produce useful data, though with modest impact. This situation can mean that research proposals with the potential to transform our understanding of a disease and offer new approaches to its treatment never reach the threshold for funding and are not implemented, even though the potential and quality of the science is acknowledged by reviewers and funding panel.

It appears that our work examining a viral cause for Alzheimer’s disease is in this category. Despite our publishing a large number of potentially very exciting papers on this topic, and despite our research projects being reviewed favourably by scientific referees, few funding panels are prepared to commit resources to fund our work, as by doing so they deny funding to other more straightforward, very low risk projects.

We are therefore actively seeking sponsorship for several projects of varying costs to investigate the interaction of virus and specific genetic factor, the pathways of viral damage in the brain, and the effects of antiviral agents. All the projects would provide significant evidence strengthening the case for trialling antiviral agents in Alzheimer’s disease.

Antiviral agents would inhibit a likely major cause of the disease in contrast to current treatments, which merely inhibit the symptoms.

If any Lifeboat member knows of a company or individual that would be interested in sponsoring some of our research on Alzheimer’s disease then please contact me for further details.

Ruth Itzhaki

Continue reading “Unique opportunity to sponsor research investigating an infectious cause and potential treatment for Alzheimer’s disease” »

May 18, 2009

Top 6 Upcoming Health Events

Posted by in categories: biotech/medical, events, futurism

The air is buzzing. People are talking about health more than ever before, and it’s good news for patients. Technology is making it possible for patients to take an active role in “participatory medicine”, partnering with their doctors to decide on the best course of action for their health.

Over the next few months, these 6 events will bring together patients, researchers, doctors, and health enthusiasts. Discussions, partnerships, and innovations will emerge. Keep your eye on these, and attend if you can!

1. TEDMED — October 27–30, http://www.tedmed.com
The medical version of the legendary TED conferences. From the TEDMED site: “The fifth in a series created by Marc Hodosh and Richard Saul Wurman, TEDMED celebrates conversations that demonstrate the intersection and connections between all things medical and healthcare related: from personal health to public health, devices to design and Hollywood to the hospital.” This year’s speakers include Dean Kamen, Craig Venter, Sanjay Gupta and Goldie Hawn..

2. Transform — September 13–15, http://centerforinnovation.mayo.edu/transform
A collaborative symposium at The Mayo Clinic Center for Innovation. From the Transform site: “Transform brings together a dynamic group of speakers and participants from inside and outside the health care industry to explore the intersections between human experience, health care delivery and new business models. Join us to imagine and create innovative ways to deliver a better health care experience in a 21st century world.”

Continue reading “Top 6 Upcoming Health Events” »

May 17, 2009

Dr. Moreau outlawed in LA — Panel Votes to Outlaw Human-Animal Hybrids

Posted by in categories: biological, biotech/medical, human trajectories

U.S. News and World Report — May 12, 2009, by KEVIN McGILL

BATON ROUGE, La.—Combining human and animal cells to create what are sometimes called “human-animal hybrids” would be a crime in Louisiana, punishable by up to 10 years in prison, under legislation approved Tuesday by a state Senate panel.

Scientific researchers in some areas have tried to create human embryonic stem cells, which scientists say could be used to develop treatment for a variety of human ailments, by placing human DNA into animal cells. But such practices are controversial for a number of reasons.

Continue reading “Dr. Moreau outlawed in LA — Panel Votes to Outlaw Human-Animal Hybrids” »

May 4, 2009

Forever Young

Posted by in categories: biological, biotech/medical, futurism, human trajectories, media & arts, space

(Crossposted on the blog of Starship Reckless)

Eleven years ago, Random House published my book To Seek Out New Life: The Biology of Star Trek. With the occasion of the premiere of the Star Trek reboot film and with my mind still bruised from the turgid awfulness of Battlestar Galactica, I decided to post the epilogue of my book, very lightly updated — as an antidote to blasé pseudo-sophistication and a reminder that Prometheus is humanity’s best embodiment. My major hope for the new film is that Uhura does more than answer phones and/or smooch Kirk.

Coda: The Infinite Frontier

star-trekA younger science than physics, biology is more linear and less exotic than its older sibling. Whereas physics is (mostly) elegant and symmetric, biology is lunging and ungainly, bound to the material and macroscopic. Its predictions are more specific, its theories less sweeping. And yet, in the end, the exploration of life is the frontier that matters the most. Life gives meaning to all elegant theories and contraptions, life is where the worlds of cosmology and ethics intersect.

Continue reading “Forever Young” »